Intellipharmaceutics (IPCI) Reports Q3 Loss of $0.08/Share

Intellipharmaceutics (NASDAQ: IPCI) reported Q3 EPS of ($0.08), versus ($0.07) reported last year. Revenue for the quarter came in at $1.2 million, versus $600 thousand reported last year.

For earnings history and earnings-related data on Intellipharmaceutics (IPCI) click here.

You May Also Be Interested In

• Brinker International (EAT) Misses Q4 EPS by 2c ; Offers Guidance
• New York City REIT Inc. (NYC) Reports Q2 Loss of $3.04
• PagSeguro Digital Ltd. (PAGS) Misses Q2 EPS by 2c